人間の再プログラミングの統合的分析は,誘発された多能性のダイナミックな性質を明らかにします
Davide Cacchiarelli1, Cole Trapnell2, Michael J Ziller1
1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Broad Institute, Cambridge, MA 02142, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
Cell
|July 18, 2015
まとめ
研究者は誘発性多能性を研究するためにヒト細胞システムを開発し,重要な遺伝子活性化段階を明らかにし,疾患モデリングと治療のための新しいレギュレータを特定しました.
科学分野:
- 幹細胞生物学
- エピジェネティクス
- ヒトの細胞の再プログラム
背景:
- 誘発性多能症は 病気のモデル化や 再生医療に 期待を寄せています
- 人間の誘発性多能性の分子メカニズムの理解は,細胞の多様性によって制限されています.
研究 の 目的:
- 誘発性多能性の高解像度分析のための信頼性の高いヒト細胞システムを確立する.
- 細胞を再プログラムする 分子原理を解明する
主な方法:
- ヒトを再プログラムできるクローンシステムの構築と特徴付け
- 統合的転写と表遺伝子プロフィール 再プログラムタイムライン
- 新しい再プログラムレギュレータを特定するための機能分析
主要な成果:
- 遺伝子ネットワークの活性化波の詳細なマッピング
- 発達レギュレータと胚のパターン遺伝子の再活性化の観察
- 誘発性多能性プロセスに不可欠な新しい調節物質の特定と検証
結論:
- 開発されたシステムは,人間の誘発された多能性を研究するための堅固なプラットフォームを提供します.
- この研究は 人間の細胞における 再プログラム化の 分子基盤の理解を深めるものです
- この発見は 病気のモデリングと 治療の応用の改善の道を開きます
関連する概念動画
Somatic to iPS Cell Reprogramming
2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Chromatin Modification in iPS Cells
2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells
4.1K
4.1K
Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K
Methods of Nuclear Reprogramming
2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K


